China SXT Pharmaceuticals (SXTC) Leases (2023 - 2025)
China SXT Pharmaceuticals (SXTC) has 3 years of Leases data on record, last reported at $176648.0 in Q1 2025.
- For Q1 2025, Leases fell 25.1% year-over-year to $176648.0; the TTM value through Mar 2025 reached $176648.0, down 25.1%, while the annual FY2025 figure was $176648.0, 25.1% down from the prior year.
- Leases reached $176648.0 in Q1 2025 per SXTC's latest filing, down from $235848.0 in the prior quarter.
- Across five years, Leases topped out at $306050.0 in Q1 2023 and bottomed at $176648.0 in Q1 2025.
- Average Leases over 3 years is $239515.3, with a median of $235848.0 recorded in 2024.
- Peak YoY movement for Leases: dropped 22.94% in 2024, then dropped 25.1% in 2025.
- A 3-year view of Leases shows it stood at $306050.0 in 2023, then dropped by 22.94% to $235848.0 in 2024, then decreased by 25.1% to $176648.0 in 2025.
- Per Business Quant database, its latest 3 readings for Leases were $176648.0 in Q1 2025, $235848.0 in Q1 2024, and $306050.0 in Q1 2023.